0241.HK

Online medical services provider Alibaba Health Information Technology Ltd. (0241.HK) said Wednesday its revenue rose 10.2% year-on-year to 14.27 billion yuan ($1.98 billion) in the six months through September. It credited the growth to a 67.5% jump in revenue from its pharmaceutical e-commerce platform business, which was partly offset by a 9.4% drop in revenue from its healthcare and digital services business.

The company’s net profit during the period, the first half of its fiscal year, surged by 72.5% to 770 million yuan. It attributed the strong gains to the revenue increase, as well as improving operational efficiencies for its self-operated pharmaceutical business, including its introduction of more top brands and expansion of its partnership channels.

The company’s stock rose 3.3% to HK$4.27 in early Thursday trade in Hong Kong.

By A. Au

To subscribe to Bamboo Works weekly free newsletter, click  here

Recent Articles

Yan Palace makes bird's nest products

Yan Palace swoops back to profit growth

China’s largest edible bird’s nest brand said its profit rose 20% to 35% in the first half of 2025, returning to bottom line growth despite pressure on revenue Key Takeaways:…
Pony AI and WeRide do robotaxis

Pony AI pulls ahead of WeRide in China robotaxi race

Both companies notched an important new advance last week when Shanghai unveiled a major expansion to its robotaxi program Key Takeaways: Pony AI, WeRide and Baidu were among groups awarded…